Risk for Severe COVID-19 Not Increased for Children With Cancer
In children with cancer younger than 16, the estimated incidence of hospital-identified SARS-CoV-2 infection was 3 percent.
In children with cancer younger than 16, the estimated incidence of hospital-identified SARS-CoV-2 infection was 3 percent.
2007 to 2016 saw increase in overall cancer incidence in all age groups, mainly driven by thyroid cancer.
Findings seen in survivors of childhood cancer independent of the neurotoxic treatment received
Risk-adapted therapy effectively prevents fungal infections and reduces neurotoxicity in children with leukemia.
Early initiation of breast cancer screening with MRI may reduce breast cancer mortality by more than half.
Comprehensive scale-up of interventions could avert 6.2 million deaths in children with cancer.
Five-year mortality from all causes overall decreased, but improvement was limited for some cancer types.
Medical and ethical considerations are discussed, including in cases of conflict between parent, child.
Greatest gaps in life expectancy seen for those receiving radiotherapy, alone or combined with chemotherapy.
Additive risk seen between combined anthracyclines and radiotherapy doses to the breast.